# Vifor Pharma (Switzerland)

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/vifor-pharma-switzerland/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 15 |
| Citations | 58,702 |
| City | Glattbrugg |
| Country | CH |
| Description | Vifor Pharma (Switzerland) is a research organisation in Glattbrugg, CH. OpenAlex records 964 works and 58,702 citations for it. 245 researchers list it as their most recent affiliation. |
| Homepage | http://www.viforpharma.com/en/ |
| OpenAlex ID | https://openalex.org/I4210102083 |
| Researchers | 245 |
| ROR ID | https://ror.org/0185z7g17 |
| Type | company |
| Works | 964 |

## University papers

- [The Economic Burden of Insulin-Related Hypoglycemia in Spain](https://scholariq.org/papers/the-economic-burden-of-insulin-related-hypoglycemia-in-spain/)
- [The Cost Effectiveness of Patiromer for the Treatment of Hyperkalaemia in Patients with Chronic Kidney Disease with and without Heart Failure in Ireland](https://scholariq.org/papers/the-cost-effectiveness-of-patiromer-for-the-treatment-of-hyperkalaemia-in/)
- [Ferric carboxymaltose for the treatment of iron deficiency in heart failure: a multinational cost‐effectiveness analysis utilising <scp>AFFIRM‐AHF</scp>](https://scholariq.org/papers/ferric-carboxymaltose-for-the-treatment-of-iron-deficiency-in-heart-failure-a/)
- [Cost-Effectiveness Analysis of Incretin Therapy for Type 2 Diabetes in Spain: 1.8 mg Liraglutide Versus Sitagliptin](https://scholariq.org/papers/cost-effectiveness-analysis-of-incretin-therapy-for-type-2-diabetes-in-spain-1-8/)
- [Self-Reported Frequency and Impact of Hypoglycemic Events in Spain](https://scholariq.org/papers/self-reported-frequency-and-impact-of-hypoglycemic-events-in-spain/)
- [Incretin Therapy for Type 2 Diabetes in Spain: A Cost-Effectiveness Analysis of Liraglutide Versus Sitagliptin](https://scholariq.org/papers/incretin-therapy-for-type-2-diabetes-in-spain-a-cost-effectiveness-analysis-of/)
- [Iron Formulations for the Treatment of Iron Deficiency Anemia in Patients with Inflammatory Bowel Disease: A Cost-Effectiveness Analysis in Switzerland](https://scholariq.org/papers/iron-formulations-for-the-treatment-of-iron-deficiency-anemia-in-patients-with/)
- [Cost of severe hypoglycaemia in nine European countries](https://scholariq.org/papers/cost-of-severe-hypoglycaemia-in-nine-european-countries/)
- [Patients&amp;rsquo; and physicians&amp;rsquo; preferences for type 2 diabetes mellitus treatments in Spain and Portugal: a&amp;nbsp;discrete choice experiment](https://scholariq.org/papers/patients-and-amp-rsquo-and-physicians-and-amp-rsquo-preferences-for-type-2/)
- [Evaluation of the Cost-Effectiveness of Iron Formulations for the Treatment of Iron Deficiency Anaemia in Patients with Inflammatory Bowel Disease in the UK](https://scholariq.org/papers/evaluation-of-the-cost-effectiveness-of-iron-formulations-for-the-treatment-of/)
- [Health Care Resource Utilization and Associated Costs Across Proteinuria and Declining Kidney Function in Patients With IgA Nephropathy: A Retrospective Study in Three European Countries](https://scholariq.org/papers/health-care-resource-utilization-and-associated-costs-across-proteinuria-and/)

## University researchers

- [Antonio Ramírez de Arellano](https://scholariq.org/researchers/antonio-ramirez-de-arellano/)

## University top topics

Showing 8 of 25.

- [Iron Metabolism and Disorders](https://scholariq.org/topics/iron-metabolism-and-disorders/)
- [Erythropoietin and Anemia Treatment](https://scholariq.org/topics/erythropoietin-and-anemia-treatment/)
- [Hemoglobinopathies and Related Disorders](https://scholariq.org/topics/hemoglobinopathies-and-related-disorders/)
- [Potassium and Related Disorders](https://scholariq.org/topics/potassium-and-related-disorders/)
- [Dermatology and Skin Diseases](https://scholariq.org/topics/dermatology-and-skin-diseases/)
- [Parathyroid Disorders and Treatments](https://scholariq.org/topics/parathyroid-disorders-and-treatments/)
- [Heart Failure Treatment and Management](https://scholariq.org/topics/heart-failure-treatment-and-management/)
- [Dialysis and Renal Disease Management](https://scholariq.org/topics/dialysis-and-renal-disease-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.